Table 2.
Characteristic | AR Level | p-value | |||
---|---|---|---|---|---|
| |||||
1 | 2 | 3 | 4 | ||
ER/PR | |||||
Positive | 3 (13.0) | 10 (43.5) | 8 (34.8) | 2 (8.7) | <0.0001 |
Negative | 65 (73.9) | 9 (10.2) | 12 (13.6) | 2 (2.3) | |
Triple Negative | |||||
Yes | 61 (76.3) | 8 (10.0) | 9 (11.3) | 2 (2.5) | <0.0001 |
No | 14 (25.9) | 15 (27.8) | 19 (35.2) | 6 (11.1) | |
ALDH1 | |||||
Positive | 29 (48.3) | 12 (20.0) | 14 (23.3) | 5 (8.3) | 0.40 |
Negative | 46 (62.2) | 11 (14.9) | 14 (18.9) | 3 (4.1) |
AR level 1= AR negative
AR level 2= AR weakly positive
AR level 3= AR moderately positive
AR level 4= AR strongly positive
Significant difference in AR level for ER/PR positive vs. ER/PR negative – most ER/PR negative have no AR level, whereas most ER/PR positive have weak-strong AR levels Significant difference in AR levels for Triple Negative vs. not TN-most TN tumors have no AR levels whereas most none-TN tumors have weak-strong AR levels
ALDH positivity distribution does not differ significantly between AR levels